Coordinate redeployment of PRC1 proteins suppresses tumor formation during Drosophila development

Vincent Loubière1,2, Anna Delest1,2, Aubin Thomas1,2

  • 1Institute of Human Genetics, UPR1142 CNRS, 141 Rue de la Cardonille, 34396, Montpellier Cedex 5, France.

Nature Genetics
|September 20, 2016
PubMed

Insights

Polycomb Repressive Complex 1 (PRC1) proteins function as tumor suppressors, regulating genes involved in cell growth independently of PRC2. This redeployment of PRC1 is conserved across species.

Area of Science:

  • Epigenetics
  • Developmental Biology
  • Cancer Biology

Background:

  • Polycomb group proteins, including PRC1 and PRC2, are crucial epigenetic regulators.
  • These complexes typically coregulate target genes, playing roles in development and disease.

Purpose of the Study:

  • To investigate the independent function of PRC1 components.
  • To identify PRC1 targets independent of PRC2 and H3K27me3.
  • To explore the evolutionary conservation of PRC1 function.

Main Methods:

  • Genome-wide mapping of PRC1 components and H3K27me3 in Drosophila.
  • Analysis of gene expression changes in PRC1 and PRC2 mutants.
  • Comparative analysis in human embryonic stem cells and differentiated cells.

Main Results:

  • PRC1 acts as a neoplastic tumor suppressor independently of PRC2.
  • A large set of proliferation, signaling, and polarity genes are targeted by PRC1 in the absence of H3K27me3.
  • These non-canonical PRC1 targets are specifically deregulated by PRC1 alterations.

Conclusions:

  • PRC1 has functions independent of PRC2, particularly in tumor suppression.
  • PRC1 is dynamically redeployed to regulate key cellular processes during development.
  • This redeployment mechanism is evolutionarily conserved from Drosophila to humans.